Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep;7(Suppl 6):S197.
doi: 10.21037/atm.2019.07.28.

Whole genome sequencing in Mycobacterium tuberculosis

Andrea Spitaleri  1 , Arash Ghodousi  1 , Paolo Miotto  1 , Daniela Maria Cirillo  1
Affiliations
Editorial

Whole genome sequencing in Mycobacterium tuberculosis

Andrea Spitaleri et al. Ann Transl Med. 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis.
    Gygli SM, Keller PM, Ballif M, Blöchliger N, Hömke R, Reinhard M, Loiseau C, Ritter C, Sander P, Borrell S, Collantes Loo J, Avihingsanon A, Gnokoro J, Yotebieng M, Egger M, Gagneux S, Böttger EC. Gygli SM, et al. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02175-18. doi: 10.1128/AAC.02175-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30718257 Free PMC article.

References

    1. Ghodousi A, Tagliani E, Karunaratne E, et al. Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms. Antimicrob Agents Chemother 2019. doi: 10.1128/AAC.00092-19 - DOI - PMC - PubMed
    1. CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, et al. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. N Engl J Med 2018;379:1403-15. - PMC - PubMed
    1. Gygli SM, Keller PM, Ballif M, et al. Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2019;63. doi: .10.1128/AAC.02175-18 - DOI - PMC - PubMed
    1. Baquero F. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 2001;4:93-105. 10.1054/drup.2001.0196 - DOI - PubMed
    1. Xu Y, Wu J, Liao S, et al. Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. Ann Clin Microbiol Antimicrob 2017;16:67. 10.1186/s12941-017-0239-4 - DOI - PMC - PubMed